Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Thomas Ichim News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Ichim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Ichim Today - Breaking & Trending Today
Creative Medical Technology Holdings Files Provisional Patent on Novel Type 1 Diabetes Immunotherapy Using Exosomes from MyeloCelz™ Platform
/PRNewswire/ -- Creative Medical Technology Holdings Inc. (OTC – CELZ) announced today filing a new patent application covering nanoparticles called "exosomes"...
Source: prnewswire.com
Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board
Press release content from PR Newswire. The AP news staff was not involved in its creation. Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board February 16, 2021 GMT ELK CITY, Idaho, Feb. 16, 2021 /PRNewswire/ -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today appointment of Dr. Boris Minev to the Scientific Advisory Board of the Company. Dr. Minev joins other internationally renowned tumor immunologists including Dr. Francesco Marincola, Dr. Santosh Kesari, and Dr. Feng Lin. ...
Source: apnews.com
Creative Medical Technology Holdings Announces Positive Data and Patent Filing Using ImmCelz® to Treat Type 1 Diabetes
/PRNewswire/ -- (OTC: CELZ) Creative Medical Technology Holdings announced positive data and filing of a patent application covering the use of ImmCelz® in...
Source: prnewswire.com
Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz® Regenerative Immunotherapy
Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz® Regenerative Immunotherapy Clinical Stage Stem Cell Company Expands its Cellular Therapy Platforms News provided by Share this article Share this article PHOENIX, Dec. 31, 2020 /PRNewswire/ -- (OTC – CELZ) Creative Medical Technology Holdings Inc. announced today positive preclinical data using ImmCelz® in treatment of a model of heart attack. Patent application #63/132472, entitled " Treatment of Heart Failure and/or Post Infarct Pathological Remodeling by Ex...
Source: prnewswire.com